Put Options

25 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $2.6 Million - $2.83 Million
8,400 Added 24.14%
43,200 $13.9 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $15.7 Million - $19.1 Million
-59,900 Reduced 63.25%
34,800 $10.9 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $11.4 Million - $13.7 Million
42,300 Added 80.73%
94,700 $26.9 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $6.09 Million - $6.87 Million
23,800 Added 83.22%
52,400 $15.1 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $2.25 Million - $2.8 Million
10,300 Added 56.28%
28,600 $7.69 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $1.84 Million - $2.18 Million
-8,600 Reduced 31.97%
18,300 $4.06 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $6.07 Million - $7.4 Million
26,900 New
26,900 $6.5 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $9.52 Million - $10.7 Million
-42,400 Reduced 83.3%
8,500 $1.92 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $3.44 Million - $3.83 Million
14,900 Added 41.39%
50,900 $12.4 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $7.41 Million - $8.2 Million
33,800 Added 1536.36%
36,000 $8.71 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $275,951 - $323,310
1,300 Added 144.44%
2,200 $468,000
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $2.1 Million - $2.33 Million
-9,000 Reduced 90.91%
900 $219,000
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $216,380 - $257,670
-1,000 Reduced 9.17%
9,900 $2.28 Million
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $1.85 Million - $2.06 Million
7,900 Added 263.33%
10,900 $2.77 Million
Q2 2020

Sep 10, 2020

SELL
$197.81 - $242.74 $118,686 - $145,644
-600 Reduced 16.67%
3,000 $708,000
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $8.36 Million - $11.1 Million
-45,900 Reduced 92.73%
3,600 $730,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $9.37 Million - $12 Million
49,500 New
49,500 $11.9 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $1.08 Million - $1.29 Million
-6,200 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $1.42 Million - $1.66 Million
-8,500 Reduced 57.82%
6,200 $1.14 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $7.07 Million - $7.97 Million
-39,100 Reduced 72.68%
14,700 $2.79 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $42.6 Million - $49.8 Million
-239,000 Reduced 81.63%
53,800 $10.5 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $11 Million - $12.3 Million
-59,100 Reduced 16.79%
292,800 $60.7 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $20 Million - $22.5 Million
120,700 Added 52.21%
351,900 $65 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $37.3 Million - $43.6 Million
220,100 Added 1982.88%
231,200 $39.4 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $1.87 Million - $2.09 Million
11,100
11,100 $1.93 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.